P407 Faecal calprotectin predicts sustained treatment response of infliximab induction therapy superior to C-reactive protein and clinical activity scores in inflammatory bowel disease
| Autor: | Mikael Holst, Maria Lönnkvist, Per M. Hellström, R Befrits, H. O. Diaz Tartera |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
musculoskeletal diseases
medicine.medical_specialty Treatment response biology business.industry digestive oral and skin physiology C-reactive protein Gastroenterology General Medicine medicine.disease Faecal calprotectin Inflammatory bowel disease Infliximab fluids and secretions Internal medicine Induction therapy biology.protein medicine business medicine.drug |
| Zdroj: | Journal of Crohn's and Colitis. 12:S310-S311 |
| ISSN: | 1876-4479 1873-9946 |
| DOI: | 10.1093/ecco-jcc/jjx180.534 |
| Popis: | Faecal calprotectin predicts sustained treatment response of infliximab induction therapy superior to C-reactive protein and clinical activity scores in inflammatory bowel disease |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|